News Brief: Biomedical Funding Dips, AD Research Feels the Pinch
If your lab has been scrimping and saving lately, you are not alone...
6389 RESULTS
Sort By:
If your lab has been scrimping and saving lately, you are not alone...
Bending to joint pressure from Congress, doctors, and the media, the NFL recently took steps to protect players with head injuries and to bolster research...
Phone companies will love this one; a new paper suggests that electromagnetic fields (EMFs) from cell phones can protect against AD—at least in mice...
Charcot-Marie-Tooth disease and spinal muscular atrophy are united by similar symptoms of progressive motor neuron degeneration...
When it comes to slowing Aβ production in Alzheimer disease, blocking either β- or γ-secretase has proven effective but comes with nasty side effects...
With newly developed quantum-dot nanoprobes, scientists can now watch individual Aβ molecules glom together into oligomers and fibrils in real time...
Tweaking the signaling pathway between cyclic AMP (cAMP) and proteins involved in memory has the potential to treat a variety of cognitive disorders...
Is where amyloid-β (Aβ) comes from important to its toxicity?...
The Aβ peptide claims the lion’s share of attention from researchers, but lately, other metabolites are grabbing the spotlight as potential purveyors of pathology...
We decided to try something novel and compile a roundup of the top news trends of the past year...
Mutations in the gene for α-synuclein, a small protein found in presynaptic terminals, were the first to be linked to familial Parkinson disease...
The mGluR5 modulator Norbin presents a possible new drug target for schizophrenia...
People with Alzheimer disease may be less likely to develop cancer, and people with cancer may have a lower risk of AD, according to a large population-based epidemiological study...
Just in time for the holidays, research shows that the protein that causes Huntington disease is liberally decked out with phosphates, acetyl groups, SUMO, and ubiquitin...
On 11 December 2009, the U.S. Food and Drug Administration (FDA) announced approval of a generic version of Aricept...